QurAlis
quralis.com
Actively hiring
Precision Medicine
Health Care
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$118.2M
4 rounds on record
Latest round
$20M
Convertible Note · Aug 2025 · 13 mo ago
Team
61
US Form 5500 (plan participants) · Dec 2025 · +11% in a year
Backers
1
Inkef
The money's age
Due for its next round
13 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 10, 2025
New executive QurAlis Announces Appointment of Manoj Malhotra, M.D., as Chief Medical Officer · businesswire
Aug 21, 2025
Raised a round Convertible Note $20M · SEC Form D
Jun 27, 2023
Partnership QurAlis and Unlearn Announce Collaboration to Accelerate and Optimize ALS Clinical Trials With Generative Artificial Intelligence Technologies · PRNewswire
Dec 20, 2022
Raised a round Venture round $60M · SEC Form D
Aug 12, 2022
Raised a round Convertible Note $5M · SEC Form D
May 1, 2020
Raised a round Venture round $33.2M · SEC Form D
2016
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Convertible Note | Aug 2025 | $20M | — | SEC Form D |
| Venture round | Dec 2022 | $60M | — | SEC Form D |
| Convertible Note | Aug 2022 | $5M | — | SEC Form D |
| Venture round | May 2020 | $33.2M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | QurAlis Corp | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Chris ThomajanExecutive OfficerSEC Form D
Kasper RoetDirector, Executive OfficerSEC Form D
Daniel ElbaumExecutive OfficerSEC Form D
Vikas SharmaExecutive OfficerSEC Form D
Angela GengeExecutive OfficerSEC Form D
Hagen CramerExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Inkef Similar startupsby what they do, their industry and backers
Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and…
About UsGET TO KNOWOur Founders The medical potential of AI and metabolite Dr. Leila Pirhajico-founderOn Beyond Genome: Opportunities and…
RNA intelligence for precision oncology. Blank Bio builds AI foundation models that help pharma teams identify the right patients for…
Cellply offers an automated platform for functional precision medicine.
The maximalist, data-driven approach to personalized medicine.
Sano’s end-to-end precision medicine platform de-risks trials, enabling clinical operations teams to move 10x faster and reduce cost by 5x.
News
QurAlis Confirms Signal of Target Engagement in ALS Patients in Phase 1 Clinical Trial of QRL-101, a Potentially Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener
QurAlis Corporation (
Read more
Report
QurAlis to Participate in Piper Sandler 37th Annual Healthcare Conference
CAMBRIDGE, Mass., November 20, 2025--QurAlis Corporation, a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of neurodegenerative and neurological disea
Read more
Report
QurAlis Announces Appointment of Manoj Malhotra, M.D., as Chief Medical Officer
QurAlis Corporation, a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alt...
Read more
Report
Pro access
Upgrade to see all 10 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Chris Thomajan
Executive Officer
Kasper Roet
Director, Executive Officer
Daniel Elbaum
Executive Officer
Vikas Sharma
Executive Officer
Angela Genge
Executive Officer
Hagen Cramer
Executive Officer
Julio Vega
Executive Officer
Shafique Virani
Executive Officer
Jason Brown
Executive Officer
Luc Dochez
Director
Amy Schulman
Director
Jonathan Fleming
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cambridge
United States
HQ
200-500 est. staff